Mannkind

MNKD-Q

NASDAQ:MNKD

1.21
0.02 (1.68%)
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension.
More at Wikipedia

Analysis and Opinions about MNKD-Q

Signal
Opinion
Expert
COMMENT
COMMENT
June 4, 2014

Has not been following this, but it caught his interest. A biotech where the founder owns a large stake and has been very successful with previous companies. Put hundreds of millions of dollars of his own money in, and it hasn’t really succeeded yet. Biotech stocks are quite speculative and the odds are this is going to pull back.

Mannkind (MNKD-Q)
June 4, 2014

Has not been following this, but it caught his interest. A biotech where the founder owns a large stake and has been very successful with previous companies. Put hundreds of millions of dollars of his own money in, and it hasn’t really succeeded yet. Biotech stocks are quite speculative and the odds are this is going to pull back.

Teal Linde
Portfolio Manager & Publisher, Linde Equity Report, Linde Equity Report
Price
$10.540
Owned
No
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »